Target type: biologicalprocess
The chemical reactions and pathways involving glutamine, 2-amino-4-carbamoylbutanoic acid. [GOC:ai]
Glutamine metabolic process encompasses a series of intricate biochemical reactions that govern the synthesis, utilization, and breakdown of glutamine, a non-essential amino acid playing a pivotal role in various biological processes. This multifaceted pathway involves a dynamic interplay between anabolic and catabolic reactions, tightly regulated to maintain cellular homeostasis and adapt to changing metabolic demands.
Glutamine synthesis primarily occurs in the liver, kidneys, and skeletal muscles, catalyzed by glutamine synthetase. This enzyme utilizes glutamate and ammonia as substrates, incorporating ammonia into glutamate to form glutamine. The process requires energy derived from ATP hydrolysis, highlighting the energetic cost associated with glutamine production.
Glutamine serves as a crucial nitrogen carrier within the body, transporting ammonia safely from various tissues to the liver and kidneys. Its role in ammonia detoxification is particularly significant, preventing the buildup of toxic ammonia levels that can disrupt cellular function and contribute to neurological dysfunction.
In addition to its nitrogen transport function, glutamine plays a vital role in several other metabolic pathways. It acts as a precursor for the synthesis of other amino acids, such as proline, arginine, and glutamate, and is essential for the production of purines and pyrimidines, the building blocks of DNA and RNA. Moreover, glutamine serves as a primary fuel source for rapidly dividing cells, including immune cells and intestinal cells, highlighting its importance in supporting cellular growth and proliferation.
Glutamine catabolism, the breakdown of glutamine, occurs primarily in the kidneys and small intestine. The enzyme glutaminase catalyzes the hydrolysis of glutamine, releasing ammonia and glutamate. This reaction contributes to ammonia excretion and provides glutamate for various metabolic processes.
The regulation of glutamine metabolism is complex and involves a sophisticated interplay of factors, including enzyme activity, substrate availability, and hormonal signals. Glutamine synthetase activity is regulated by the availability of its substrates, glutamate and ammonia, as well as by allosteric modulation by various metabolites. Glutaminase activity, on the other hand, is influenced by hormonal signals such as insulin and glucagon, which regulate its expression and activity.
In conclusion, glutamine metabolic process is an essential and multifaceted pathway that plays a vital role in nitrogen metabolism, amino acid synthesis, cellular growth, and ammonia detoxification. This intricate process involves a dynamic interplay between anabolic and catabolic reactions, tightly regulated to maintain cellular homeostasis and adapt to changing metabolic demands.'
"
Protein | Definition | Taxonomy |
---|---|---|
Glutamate dehydrogenase 1, mitochondrial | [no definition available] | Bos taurus (cattle) |
Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 | A glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q06210] | Homo sapiens (human) |
GMP synthase [glutamine-hydrolyzing] | A GMP synthase [glutamine-hydrolyzing] that is encoded in the genome of human. [PRO:DNx, UniProtKB:P49915] | Homo sapiens (human) |
CAD protein | A multifunctional protein CAD that is encoded in the genome of human. [PRO:DNx, UniProtKB:P27708] | Homo sapiens (human) |
Asparagine synthetase [glutamine-hydrolyzing] | An asparagine synthetase [glutamine-hydrolyzing] that is encoded in the genome of human. [PRO:DNx, UniProtKB:P08243] | Homo sapiens (human) |
D-3-phosphoglycerate dehydrogenase | A D-3-phosphoglycerate dehydrogenase that is encoded in the genome of human. [PRO:DNx, UniProtKB:O43175] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
ureidosuccinic acid | N-carbamoylaspartic acid : An N-carbamoylamino acid that is aspartic acid with one of its amino hydrogens replaced by a carbamoyl group. ureidosuccinic acid: RN given refers to (DL)-isomer | aspartic acid derivative; C4-dicarboxylic acid; N-carbamoyl-amino acid | Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite |
nad | NAD | geroprotector | |
nicotinamide mononucleotide | Nicotinamide Mononucleotide: 3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5'phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN. | nicotinamide mononucleotide | Escherichia coli metabolite; mouse metabolite |
psicofuranine | psicose derivative; purine nucleoside | ||
angustmycin a | angustmycin A: structure; from Streptomyces hygroscopicus; inhibits GMP synthesis | 6-aminopurines | |
aaptamine | aaptamine: natural product from sea sponge Aaptos aaptos; structure given in first source; RN from CA Index Guide 1984 | ||
tiazofurin | tiazofurin: RN given refers to (beta-D)-isomer; structure given in first source tiazofurine : A C-glycosyl compound that is 1,3-thiazole-4-carboxamide in which the hydrogen at position 2 has been replaced by a beta-D-ribofuranosyl group. It is metabolised to thiazole-4-carboxamide adenine dinucleotide (TAD), a selective inhibitor of inosine monophosphate dehydrogenase (IMP dehydrogenase). | 1,3-thiazoles; C-glycosyl compound; monocarboxylic acid amide | antineoplastic agent; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; prodrug |
cysteine sulfinic acid | 3-sulfino-L-alanine : The organosulfinic acid arising from oxidation of the sulfhydryl group of L-cysteine. | organosulfinic acid; S-substituted L-cysteine | Escherichia coli metabolite; human metabolite; metabotropic glutamate receptor agonist; mouse metabolite |
n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid | N(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid : A monocarboxylic acid amide obtained by the formal condensation of the terminal amino group of 3-amino-L-alanine with the carboxy group of (2E)-4-methoxy-4-oxobut-2-enoic acid. N(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid: inhibits glucosamine synthetase in E coli; structure given in first source; RN given refers to (S-(E)-isomer) | enoate ester; methyl ester; monocarboxylic acid amide | metabolite |
N-(4,6-dimethyl-2-pyridinyl)-4-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinecarbothioamide | piperazines; pyridines |